Blog
RSS FeedPosted by Michael Wonder on 03 Feb 2022
Addressing uncertainty in relative effectiveness assessments by HTA organisations
31 January 2022 - This study outlines the ways in which different health technology assessment organizations deal with uncertainty in relative ...
Posted by Michael Wonder on 02 Feb 2022
Understanding innovation of health technology assessment methods: the IHTAM framework
31 January 2022 - Adequate methods are urgently needed to guarantee the good practice of health technology assessment for technologies with ...
Posted by Michael Wonder on 19 Jan 2022
UK’s NICE to launch sweeping changes to drug assessments to be faster, more agile
19 January 2022 - The health technology assessment body has been under pressure from drugmakers and patient groups for years to ...
Posted by Michael Wonder on 27 Nov 2021
Radical or not, NICE makes evidence based recommendations
19 November 2021 - Godlee’s call for the National Institute for Health and Care Excellence to keep close to its radical ...
Posted by Michael Wonder on 06 Oct 2021
Aetion and NICE announce collaboration to explore use of real world evidence for comparative effectiveness studies to inform clinical guidance
6 October 2021 - Collaboration will leverage the Aetion Evidence Platform to study when and how real world evidence can support ...
Posted by Michael Wonder on 18 Jul 2021
Considering and communicating uncertainty in health technology assessment
15 July 2021 - As health technology assessment seeks to combine complex sets of evidence, values, and perspectives to support open, ...
Posted by Michael Wonder on 17 Jun 2021
Shared decision making underpins good health care
17 June 2021 - Shared decision making between service users and health care professionals is an integral part of health care, ...
Posted by Michael Wonder on 15 Jun 2021
How the patient voice is becoming vital for drug approval
14 June 2021 - Rebecca Sanders from Lipodystrophy UK tells us how the patient voice helped convince NICE to approve a ...
Posted by Michael Wonder on 28 Apr 2021
Do existing real world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal
28 April 2021 - Technological and computational advancements offer new tools for the collection and analysis of real world data. ...
Posted by Michael Wonder on 28 Apr 2021
NICE signs up to join the GetReal Institute
28 April 2021 -NICE’s ambition complements the GetReal Institute’s core mission to facilitate the adoption and implementation of real-world evidence ...
Posted by Michael Wonder on 12 Apr 2021
Prevalence of immature survival data for anti-cancer drugs presented to the National Institute for Health and Care Excellence and impact on decision-making
12 April 2021 - This research aims to explore how often NICE uses immature overall survival data to inform reimbursement ...
Posted by Michael Wonder on 01 Feb 2021
Determinants of managed entry agreements in the context of health technology assessment: a comparative analysis of oncology therapies in four countries
29 January 2021 - Managed entry agreements are increasingly used to address uncertainties arising in the health technology assessment process due ...
Posted by Michael Wonder on 22 Dec 2020
Shared decision making is an integral part of healthcare, says NICE
22 December 2020 - Shared decision making between patients and clinicians should be embedded throughout healthcare services, says NICE, in draft ...
Posted by Michael Wonder on 12 Nov 2020
Expertise, experience, and excellence. Twenty years of patient involvement in health technology assessment at NICE: an evolving story
10 November 2020 - From its inception in 1999, NICE committed to including the expertise, experiences, and perspectives of lay people, ...
Posted by Michael Wonder on 16 Oct 2020
NICE gears up to support world evidence-based health care day
16 October 2020 - Inaugural World Evidence-based Health care Day takes place on Tuesday 20 October 2020. ...